Mark E. Lasbury
Impact in
- Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections
- Fungal Infections and Studies
- Physiology top 10%
- Adenosine and Purinergic Signaling
Papers in
- Epidemiology 37
- Pneumocystis jirovecii pneumonia detection and treatment 37
- Pneumonia and Respiratory Infections 17
-
- Tuberculosis Research and Epidemiology 13
- HIV/AIDS drug development and treatment 8
- Co-authors
- Pamela J. Durant (35 shared papers)Chao-Hung Lee (11 shared papers)Chao‐Hung Lee (23 shared papers)Chung-Ping Liao (7 shared papers)Chen Zhang (8 shared papers)Marilyn S. Bartlett (8 shared papers)Chad Ray (4 shared papers)Scott A. Rivkees (2 shared papers)
- Journals
- Infection and Immunity (6 papers)Journal of Biological Chemistry (3 papers)Journal of Eukaryotic Microbiology (19 papers)Journal of Clinical Microbiology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Mark E. Lasbury
50 papers receiving 482 citations
Peers
Comparison fields: 5 of 66
- Epidemiology 289
- Physiology 41
- Infectious Diseases 150
- Immunology 88
- Endocrine and Autonomic Systems 15
Countries citing papers authored by Mark E. Lasbury
This map shows the geographic impact of Mark E. Lasbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Lasbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Lasbury more than expected).
Fields of papers citing papers by Mark E. Lasbury
This network shows the impact of papers produced by Mark E. Lasbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Lasbury. The network helps show where Mark E. Lasbury may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Lasbury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 56 | |
| 2 | 2006 | 42 | |
| 3 | 2007 | 41 | |
| 4 | 2003 | 39 | |
| 5 | 2003 | 38 | |
| 6 | 1995 | 36 | |
| 7 | 2004 | 26 | |
| 8 | 2009 | 19 | |
| 9 | 2010 | 19 | |
| 10 | 2008 | 18 | |
| 11 | 2000 | 16 | |
| 12 | 2000 | 15 | |
| 13 | 2010 | 14 | |
| 14 | 2001 | 11 | |
| 15 | 2009 | 9 | |
| 16 | 2010 | 8 | |
| 17 | 2001 | 7 | |
| 18 | 2009 | 6 | |
| 19 | 2006 | 6 | |
| 20 | 2002 | 6 |
About Mark E. Lasbury
Mark E. Lasbury is a scholar working on Epidemiology, Infectious Diseases, Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 492 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (37 papers), Pneumonia and Respiratory Infections (17 papers), Tuberculosis Research and Epidemiology (13 papers), HIV/AIDS drug development and treatment (8 papers), Synthesis and Biological Evaluation (8 papers), Polyamine Metabolism and Applications (4 papers), Adenosine and Purinergic Signaling (3 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Epidemiology (289 citations), Physiology (41 citations), Infectious Diseases (150 citations), Immunology (88 citations) and Endocrine and Autonomic Systems (15 citations). Mark E. Lasbury has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Pamela J. Durant, Chao-Hung Lee, Chao‐Hung Lee, Chung-Ping Liao, Chen Zhang, Marilyn S. Bartlett, Chad Ray, Scott A. Rivkees, Xing Tang and James W. Smith. Their work appears in journals such as Infection and Immunity, Journal of Biological Chemistry, Journal of Eukaryotic Microbiology, Journal of Clinical Microbiology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.